<?xml version="1.0" encoding="UTF-8"?><subLeg xmlns="http://www.xml.gov.hk/schemas/hklm/1.0" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.xml.gov.hk/schemas/hklm/1.0 https://www.elegislation.gov.hk/schemas/hklm.xsd" identifier="/hk/cap599K!en" xml:lang="en"><meta><docType>cap</docType><docNumber>599K</docNumber><docStatus>In effect</docStatus><docName>Cap. 599 sub. leg. K</docName><dc:identifier>/hk/cap599K!en</dc:identifier><dc:date>2023-01-20</dc:date><dc:subject>legislation</dc:subject><dc:language>en</dc:language><dc:publisher>DoJ</dc:publisher><dc:rights>The Government of the Hong Kong Special Administrative Region</dc:rights></meta><main><docTitle startPeriod="2020-12-24" status="operational" reason="inEffect" id="ID_1608721337209_001" name="shortTitle" temporalId="shortTitle">
            <content>Prevention and Control of Disease (Use of Vaccines) Regulation</content>
        </docTitle><enactingFormula>(Made by the Chief Executive in Council under
                <ref href="/hk/cap599/s8">section 8</ref> of the Prevention and Control of Disease
            Ordinance (<ref href="/hk/cap599">Cap. 599</ref>))</enactingFormula><commencementNote>[24 December 2020]</commencementNote><part id="ID_1662523262508_001" name="P1" temporalId="P1" startPeriod="2022-09-09" status="operational" reason="inEffect"><num value="1">Part 1</num><heading>Preliminary</heading><sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote><section startPeriod="2020-12-24T00:00:00" status="operational" reason="inEffect" id="ID_1608721337428_002" name="s1" temporalId="s1"><num value="1">1.</num><heading>Commencement</heading><content>This Regulation comes into operation on 24 December 2020.</content></section><section startPeriod="2022-09-09" status="operational" reason="inEffect" id="ID_1608721337443_003" name="s2" temporalId="s2"><num value="2">2.</num><heading>Interpretation</heading><subsection id="ID_1662618838360_001" name="1" temporalId="s2_1"><num value="1">(1)</num><leadIn>In this Regulation—
        <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></leadIn><def name="AdvisoryPanel"><term>advisory panel</term> (<term xml:lang="zh-Hant-HK">顧問專家委員會</term>) means the panel appointed under <ref>section 9</ref>;</def><def name="Authorization"><term>authorization</term> (<term xml:lang="zh-Hant-HK">認可</term>)
        means an authorization granted under <ref>section 3(1)</ref>;</def><def name="AuthorizationApplicant"><term>authorization applicant</term> (<term xml:lang="zh-Hant-HK">申請認可者</term>), in relation to an authorization, means the person on
        whose application the authorization is granted;</def><def name="AuthorizedOfficer"><term>authorized officer</term> (<term xml:lang="zh-Hant-HK">獲授權人員</term>) means a public officer appointed under <ref>section 8B(1)</ref>;
          <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></def><def name="AuthorizedVaccine"><term>authorized vaccine</term> (<term xml:lang="zh-Hant-HK">認可疫苗</term>) means a non-registered vaccine that is authorized under <ref>section
          3(1)</ref>;</def><def name="Cap138A"><term><ref href="/hk/cap138A">Cap. 138A</ref></term> (<term xml:lang="zh-Hant-HK">《<ref href="/hk/cap138A">第138A章</ref>》</term>) means the Pharmacy
        and Poisons Regulations (<ref href="/hk/cap138A">Cap. 138 sub. leg. A</ref>);</def><def name="Dispense"><term>dispense</term> (<term xml:lang="zh-Hant-HK">配發</term>) has the
        meaning given by <ref>section 2(1)</ref> of the Pharmacy and Poisons Ordinance (<ref href="/hk/cap138">Cap. 138</ref>); <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></def><def name="Function"><term>function</term> (<term xml:lang="zh-Hant-HK">職能</term>) includes a
        power and a duty; <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></def><def name="GovernmentVaccinationProgramme"><term>Government vaccination programme</term>
          (<term xml:lang="zh-Hant-HK">政府疫苗接種計劃</term>) means a programme that is conducted by the
        Government to administer specified vaccines to members of the public, or a section of the
        public, for—<paragraph id="ID_1662618838376_002" name="a" temporalId="s2_1_a"><num value="a">(a)</num><content>preventing, protecting against, delaying or otherwise controlling the incidence
            or transmission of the specified disease; or</content></paragraph><paragraph id="ID_1662618838377_003" name="b" temporalId="s2_1_b"><num value="b">(b)</num><content>mitigating a serious or life-threatening condition arising from the specified
            disease; <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></content></paragraph></def><def name="NonregisteredVaccine"><term>non-registered vaccine</term> (<term xml:lang="zh-Hant-HK">非註冊疫苗</term>) means a vaccine that is not registered;</def><def name="PharmaceuticalProduct"><term>pharmaceutical product</term> (<term xml:lang="zh-Hant-HK">藥劑製品</term>) has the meaning given by <ref>section 2(1)</ref> of the
        Pharmacy and Poisons Ordinance (<ref href="/hk/cap138">Cap. 138</ref>);</def><def name="Recipient"><term>recipient</term> (<term xml:lang="zh-Hant-HK">接種者</term>), in
        relation to a vaccine, means the person to whom the vaccine is administered;</def><def name="Registered"><term>registered</term> (<term xml:lang="zh-Hant-HK">註冊</term>), in
        relation to a vaccine, means registered under <ref>regulation 36</ref> of
          <ref href="/hk/cap138A">Cap. 138A</ref>;
        <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></def><def name="Secretary"><term>Secretary</term> (<term xml:lang="zh-Hant-HK">局長</term>) means the
        Secretary for Health; <sourceNote>(<ref href="hk/2022/ln144">L.N. 144 of
          2022</ref>)</sourceNote></def><def name="SpecifiedDisease"><term>specified disease</term> (<term xml:lang="zh-Hant-HK">指明疾病</term>) means the coronavirus disease 2019 (COVID-19), which is specified in item 8A
        of <ref>Schedule 1</ref> to the Ordinance;</def><def name="SpecifiedPurpose"><term>specified purpose</term> (<term xml:lang="zh-Hant-HK">指明目的</term>) means—<paragraph id="ID_1608721337584_004" name="a" temporalId="s2_1_a"><num value="a">(a)</num><content>the purpose of carrying out a
            Government
            vaccination programme;
            or</content></paragraph><paragraph id="ID_1608721337600_005" name="b" temporalId="s2_1_b"><num value="b">(b)</num><leadIn>any other reasonable purpose that—</leadIn><subparagraph id="ID_1608721337600_006" name="1" temporalId="s2_1_b_1"><num value="1">(i)</num><content>relates to the use of
              a
              specified vaccine for preventing, protecting against, delaying or
              otherwise controlling the incidence or transmission of, or mitigating a serious or
              life-threatening condition arising from, the specified disease; and</content></subparagraph><subparagraph id="ID_1608721337615_007" name="2" temporalId="s2_1_b_2"><num value="2">(ii)</num><content>is specified by the Secretary;
              <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></content></subparagraph></paragraph></def><def name="SpecifiedVaccine"><term>specified vaccine</term> (<term xml:lang="zh-Hant-HK">指明疫苗</term>) means—<paragraph id="ID_1662618838420_004" name="a" temporalId="s2_1_a"><num value="a">(a)</num><content>an authorized vaccine; or</content></paragraph><paragraph id="ID_1662618838421_005" name="b" temporalId="s2_1_b"><num value="b">(b)</num><content>a registered vaccine; <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></content></paragraph></def><def name="Use"><term>use</term> (<term xml:lang="zh-Hant-HK">使用</term>), in relation to a
        vaccine, includes distribute, supply, offer for supply, possess, prescribe, dispense and
        administer;</def><def name="Vaccine"><term>vaccine</term> (<term xml:lang="zh-Hant-HK">疫苗</term>) means a
        pharmaceutical product that—<paragraph id="ID_1608721337631_008" name="a" temporalId="s2_1_a"><num value="a">(a)</num><content>contains an antigenic substance or is intended to stimulate, after the product
            has been administered to a person, the production of an antigenic substance in that
            person’s body; and</content></paragraph><paragraph id="ID_1608721337631_009" name="b" temporalId="s2_1_b"><num value="b">(b)</num><content>is intended to stimulate a person’s immune system to produce immunity to the
            specified disease.</content></paragraph></def></subsection><subsection id="ID_1662618838424_006" name="2" temporalId="s2_2"><num value="2">(2)</num><leadIn>For the purposes of this Regulation, a person is responsible for administering a
        vaccine to a recipient if—</leadIn><paragraph id="ID_1662618838425_007" name="a" temporalId="s2_2_a"><num value="a">(a)</num><content>the person administers the vaccine to the recipient; or</content></paragraph><paragraph id="ID_1662618838426_008" name="b" temporalId="s2_2_b"><num value="b">(b)</num><content>the person is a registered medical practitioner who supervises the administration
          of the vaccine to the recipient. <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></content></paragraph></subsection></section></part><part id="ID_1662523298935_001" name="P2" temporalId="P2" startPeriod="2022-09-09" status="operational" reason="inEffect"><num value="2">Part 2</num><heading>Authorization
            of Vaccine</heading><sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote><section startPeriod="2022-09-09" status="operational" reason="inEffect" id="ID_1608721337631_010" name="s3" temporalId="s3"><num value="3">3.</num><heading>Secretary may authorize vaccine for specified purpose</heading><subsection id="ID_1608721337631_011" name="1" temporalId="s3_1"><num value="1">(1)</num><content>The
                Secretary may, on application, authorize a non-registered vaccine for a specified purpose.
                <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></content></subsection><subsection id="ID_1608721337631_012" name="2" temporalId="s3_2"><num value="2">(2)</num><leadIn>The application must be—</leadIn><paragraph id="ID_1608721337646_013" name="a" temporalId="s3_2_a"><num value="a">(a)</num><leadIn>made by—</leadIn><subparagraph id="ID_1608721337646_014" name="1" temporalId="s3_2_a_1"><num value="1">(i)</num><content>for a vaccine that satisfies the condition referred to in subsection <ref>(4)(a)(i)</ref>—a person who, in relation to the vaccine, is one described in <ref>regulation 36(1)(a)</ref>, (b) or (c) of <ref href="/hk/cap138A">Cap. 138A</ref>; or</content></subparagraph><subparagraph id="ID_1608721337646_015" name="2" temporalId="s3_2_a_2"><num value="2">(ii)</num><leadIn>for a vaccine that satisfies the condition referred to in subsection <ref>(4)(a)(ii)</ref>—</leadIn><subparagraph role="subSubparagraph" id="ID_1608721337646_016" name="A" temporalId="s3_2_a_2_A"><num value="A">(A)</num><content>a person described in subparagraph (i); or</content></subparagraph><subparagraph role="subSubparagraph" id="ID_1608721337646_017" name="B" temporalId="s3_2_a_2_B"><num value="B">(B)</num><content>a manufacturer of the vaccine outside Hong Kong, or a branch, subsidiary, representative, agent or distributor of the manufacturer; and</content></subparagraph></subparagraph></paragraph><paragraph id="ID_1608721337662_018" name="b" temporalId="s3_2_b"><num value="b">(b)</num><content>made in the manner, and accompanied by the information, specified by the Secretary.</content></paragraph></subsection><subsection id="ID_1608721337662_019" name="3" temporalId="s3_3"><num value="3">(3)</num><leadIn>Before the Secretary authorizes a vaccine, the Secretary must, having regard to the advice of the advisory panel, take into consideration—</leadIn><paragraph id="ID_1608721337662_020" name="a" temporalId="s3_3_a"><num value="a">(a)</num><content>the safety of the vaccine;</content></paragraph><paragraph id="ID_1608721337662_021" name="b" temporalId="s3_3_b"><num value="b">(b)</num><content>the efficacy of the vaccine; and</content></paragraph><paragraph id="ID_1608721337662_022" name="c" temporalId="s3_3_c"><num value="c">(c)</num><content>the quality of the vaccine.</content></paragraph></subsection><subsection id="ID_1608721337662_023" name="4" temporalId="s3_4"><num value="4">(4)</num><leadIn>The Secretary may authorize a vaccine only if—</leadIn><paragraph id="ID_1608721337678_024" name="a" temporalId="s3_4_a"><num value="a">(a)</num><leadIn>the vaccine satisfies any of the following conditions—</leadIn><subparagraph id="ID_1608721337678_025" name="1" temporalId="s3_4_a_1"><num value="1">(i)</num><content>a regulatory authority in a place outside Hong Kong that performs the function of approving pharmaceutical products for use in that place has approved, whether or not with any condition, limitation or restriction, the vaccine for administration to persons other than on an experimental or trial basis, including for emergency use;</content></subparagraph><subparagraph id="ID_1608721337693_026" name="2" temporalId="s3_4_a_2"><num value="2">(ii)</num><content>the vaccine is listed in accordance with the emergency use listing
                        procedure by WHO or is in the list of prequalified vaccines published by
                        WHO;
                        and</content></subparagraph></paragraph><paragraph id="ID_1608721337693_027" name="b" temporalId="s3_4_b"><num value="b">(b)</num><content>the Secretary considers that, for making the vaccine available
                    to
                    deal with the threat to public health posed by the specified disease, the
                    authorization is necessary and is in the public interest.
                    <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></content></paragraph><paragraph id="ID_1608721337693_028" name="c" temporalId="s3_4_c"><num value="c">(c)</num><sourceNote>(Repealed <ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></paragraph></subsection><subsection id="ID_1608721337725_029" name="5" temporalId="s3_5"><num value="5">(5)</num><leadIn>On determining an application for an authorization, the Secretary must—</leadIn><paragraph id="ID_1608721337725_030" name="a" temporalId="s3_5_a"><num value="a">(a)</num><content>notify the person who makes the application of the decision in writing; and</content></paragraph><paragraph id="ID_1608721337725_031" name="b" temporalId="s3_5_b"><num value="b">(b)</num><content>if the Secretary refuses the application—state the grounds for the refusal in the notification.</content></paragraph></subsection><subsection id="ID_1608721337725_032" name="6" temporalId="s3_6"><num value="6">(6)</num><leadIn>If the Secretary decides to grant an authorization, the Secretary must publish a notice of the authorization in the Gazette stating—</leadIn><paragraph id="ID_1608721337725_033" name="a" temporalId="s3_6_a"><num value="a">(a)</num><content>the name of the vaccine authorized;</content></paragraph><paragraph id="ID_1608721337725_034" name="b" temporalId="s3_6_b"><num value="b">(b)</num><content>the date on which the authorization takes effect;</content></paragraph><paragraph id="ID_1608721337725_035" name="c" temporalId="s3_6_c"><num value="c">(c)</num><content>the name and address of the authorization applicant;</content></paragraph><paragraph id="ID_1608721337740_036" name="d" temporalId="s3_6_d"><num value="d">(d)</num><content>the name and address of the manufacturer of the vaccine; and</content></paragraph><paragraph id="ID_1608721337740_037" name="e" temporalId="s3_6_e"><num value="e">(e)</num><content>the conditions (if any) attached to the authorization under <ref>section 4</ref>.</content></paragraph></subsection><subsection id="ID_1608721337740_038" name="7" temporalId="s3_7"><num value="7">(7)</num><leadIn>In this section—</leadIn><def name="Approve"><term>approve</term> (<term xml:lang="zh-Hant-HK">批准</term>) includes authorize and permit (however described).</def></subsection></section><section startPeriod="2020-12-24T00:00:00" status="operational" reason="inEffect" id="ID_1608721337740_039" name="s4" temporalId="s4"><num value="4">4.</num><heading>Conditions of authorization</heading><subsection id="ID_1608721337740_040" name="1" temporalId="s4_1"><num value="1">(1)</num><leadIn>The Secretary may, after having regard to the advice of the advisory panel—</leadIn><paragraph id="ID_1608721337740_041" name="a" temporalId="s4_1_a"><num value="a">(a)</num><content>attach to an authorization any condition that the Secretary considers appropriate;</content></paragraph><paragraph id="ID_1608721337740_042" name="b" temporalId="s4_1_b"><num value="b">(b)</num><content>vary the condition; or</content></paragraph><paragraph id="ID_1608721337740_043" name="c" temporalId="s4_1_c"><num value="c">(c)</num><content>revoke the condition.</content></paragraph></subsection><subsection id="ID_1608721337756_044" name="2" temporalId="s4_2"><num value="2">(2)</num><leadIn>If the Secretary varies or revokes a condition attached to an authorization, the Secretary must—</leadIn><paragraph id="ID_1608721337756_045" name="a" temporalId="s4_2_a"><num value="a">(a)</num><content>notify the authorization applicant in writing of the variation or revocation; and</content></paragraph><paragraph id="ID_1608721337756_046" name="b" temporalId="s4_2_b"><num value="b">(b)</num><content>publish a notice of the variation or revocation in the Gazette.</content></paragraph></subsection></section><section startPeriod="2023-01-20" status="operational" reason="inEffect" id="ID_1608721337756_047" name="s5" temporalId="s5"><num value="5">5.</num><heading>Effective period of authorization</heading><subsection id="ID_1608721337771_048" name="1" temporalId="s5_1"><num value="1">(1)</num><leadIn>An authorization of a vaccine—</leadIn><paragraph id="ID_1608721337771_049" name="a" temporalId="s5_1_a"><num value="a">(a)</num><content>takes effect on the date referred to in <ref>section 3(6)(b)</ref>;
                    and</content></paragraph><paragraph id="ID_1608721337771_050" name="b" temporalId="s5_1_b"><num value="b">(b)</num><leadIn>ceases to have effect when—</leadIn><subparagraph id="ID_1608721337771_051" name="1" temporalId="s5_1_b_1"><num value="1">(i)</num><content>the authorization is revoked under <ref>section 6</ref>; or</content></subparagraph><subparagraph id="ID_1608721337771_052" name="2" temporalId="s5_1_b_2"><num value="2">(ii)</num><content>if the authorization is not so revoked—the period referred to in
                        subsection (2) expires.</content></subparagraph></paragraph></subsection><subsection id="ID_1608721337771_053" name="2" temporalId="s5_2"><num value="2">(2)</num><content>For the purposes of subsection <ref>(1)(b)(ii)</ref>, the period is a period of
                12 months after the date on which the authorization takes effect, but the Secretary
                may, by notice published in the
                    Gazette<inline class="force_orig_font">*</inline>, extend the period, each
                time for a period of not more than 6 months.</content></subsection></section><editorialNote type="footnote" id="ID_1674705505169_001">
        <content> Editorial Note:</content>
        <content><inline class="force_orig_font">*</inline> Please visit
                the <a xmlns="http://www.w3.org/1999/xhtml" class="font_size_9" href="https://www.gld.gov.hk/egazette/english/search_gazette/search.php?Years%5B%5D=2023&amp;Years%5B%5D=2022&amp;Years%5B%5D=2021&amp;NoticeNo=&amp;Title=Use+of+Vaccines&amp;type=mg&amp;submit=Search">Gazette website</a> maintained by the Government Logistics Department for the
            vaccine
            authorization
            from 2021 to
            2023.</content>
    </editorialNote><section startPeriod="2020-12-24T00:00:00" status="operational" reason="inEffect" id="ID_1608721337771_054" name="s6" temporalId="s6"><num value="6">6.</num><heading>Revocation of authorization</heading><subsection id="ID_1608721337771_055" name="1" temporalId="s6_1"><num value="1">(1)</num><content>The Secretary may, after having regard to the advice of the advisory panel, revoke an authorization.</content></subsection><subsection id="ID_1608721337787_056" name="2" temporalId="s6_2"><num value="2">(2)</num><leadIn>Without limiting subsection (1), the Secretary may revoke an authorization if—</leadIn><paragraph id="ID_1608721337787_057" name="a" temporalId="s6_2_a"><num value="a">(a)</num><content>the Secretary considers that the risks of the authorized vaccine outweigh its benefits; or</content></paragraph><paragraph id="ID_1608721337787_058" name="b" temporalId="s6_2_b"><num value="b">(b)</num><content>a condition attached to the authorization is not complied with.</content></paragraph></subsection><subsection id="ID_1608721337787_059" name="3" temporalId="s6_3"><num value="3">(3)</num><leadIn>If the Secretary revokes an authorization, the Secretary must—</leadIn><paragraph id="ID_1608721337787_060" name="a" temporalId="s6_3_a"><num value="a">(a)</num><content>notify the authorization applicant in writing of the revocation stating the grounds for the revocation; and</content></paragraph><paragraph id="ID_1608721337787_061" name="b" temporalId="s6_3_b"><num value="b">(b)</num><content>publish a notice of the revocation in the Gazette.</content></paragraph></subsection></section></part><part id="ID_1662523336292_001" name="P3" temporalId="P3" startPeriod="2022-09-09" status="operational" reason="inEffect"><num value="3">Part 3</num><heading>Use of
            Vaccine</heading><sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote><section startPeriod="2022-09-09" status="operational" reason="inEffect" id="ID_1608721337787_062" name="s7" temporalId="s7"><num value="7">7.</num><heading>Use of vaccine</heading><subsection id="ID_1608721337787_063" name="1" temporalId="s7_1"><num value="1">(1)</num><leadIn><ref>Regulations 36(1)</ref> and <ref>38(1)</ref> of, and <ref>paragraph 12 of
                    Schedule 5</ref> to, <ref href="/hk/cap138A">Cap. 138A</ref> (<b><i>relevant
                        provisions</i></b>) do not apply in relation to—</leadIn><paragraph id="ID_1608721337803_064" name="a" temporalId="s7_1_a"><num value="a">(a)</num><content>the supply by a person of a non-registered vaccine to the Government under
                    a Government contract; or</content></paragraph><paragraph id="ID_1608721337803_065" name="b" temporalId="s7_1_b"><num value="b">(b)</num><content>the possession by a person of a non-registered vaccine for the purpose of
                    the performance (by that person or another person) of a Government
                    contract.</content></paragraph></subsection><subsection id="ID_1608721337803_066" name="2" temporalId="s7_2"><num value="2">(2)</num><content>The relevant provisions do not apply in relation to the use of an authorized
                vaccine for a specified purpose.</content></subsection><subsection id="ID_1662602173575_001" name="2A" temporalId="s7_2A"><num value="2A">(2A)</num><leadIn>For a registered vaccine to be used for a specified purpose, if a change of any
                of the registrable particulars of the vaccine is approved under <ref>regulation
                    36A</ref> of <ref href="/hk/cap138A">Cap. 138A</ref>—</leadIn><paragraph id="ID_1662602173577_002" name="a" temporalId="s7_2A_a"><num value="a">(a)</num><content>despite the change and <ref>regulations 36(1B)</ref> and
                        <ref>36A(6)(a)</ref> of <ref href="/hk/cap138A">Cap. 138A</ref>, the vaccine
                    is taken to remain registered; and</content></paragraph><paragraph id="ID_1662602173579_003" name="b" temporalId="s7_2A_b"><num value="b">(b)</num><content><ref>regulation 36A(6)(b)</ref> and (c) of <ref href="/hk/cap138A">Cap.
                        138A</ref> does not apply in relation to the change. <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></content></paragraph></subsection><subsection id="ID_1608721337803_067" name="3" temporalId="s7_3"><num value="3">(3)</num><content>If
                specified
                vaccines are administered to recipients in Hong Kong for a specified purpose, the
                Secretary must put in place a mechanism for monitoring any adverse event occurred to
                the recipients associated with the administration of the vaccines.
                <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></content></subsection><subsection id="ID_1608721337803_068" name="4" temporalId="s7_4"><num value="4">(4)</num><leadIn>In this section—</leadIn><def name="GovernmentContract"><term>Government contract</term> (<term xml:lang="zh-Hant-HK">政府合約</term>) means a contract to which the Government is a
                party;
                    <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></def><def name="RegistrableParticulars"><term>registrable particulars</term> (<term xml:lang="zh-Hant-HK">須註冊詳情</term>) has the meaning given by <ref>regulation
                    35A</ref> of <ref href="/hk/cap138A">Cap. 138A</ref>. <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></def></subsection></section><section startPeriod="2022-09-09" status="operational" reason="inEffect" id="ID_1608721337803_069" name="s8" temporalId="s8"><num value="8">8.</num><heading>Authorized vaccine to be administered with informed consent</heading><subsection id="ID_1608721337803_070" name="1" temporalId="s8_1"><num value="1">(1)</num><leadIn>Each person who is responsible for administering an authorized vaccine to a recipient for a specified purpose must ensure that, before the vaccine is so administered—</leadIn><paragraph id="ID_1608721337818_071" name="a" temporalId="s8_1_a"><num value="a">(a)</num><leadIn>the following person has been informed that the vaccine is authorized under this Regulation instead of registered and of any other information as may be specified by the Secretary—</leadIn><subparagraph id="ID_1608721337818_072" name="1" temporalId="s8_1_a_1"><num value="1">(i)</num><content>the recipient; or</content></subparagraph><subparagraph id="ID_1608721337818_073" name="2" temporalId="s8_1_a_2"><num value="2">(ii)</num><content>if the recipient is not legally capable of giving consent to the administration of the vaccine (<i><b>relevant consent</b></i>)—a person who is legally capable of giving the relevant consent on the recipient’s behalf; and</content></subparagraph></paragraph><paragraph id="ID_1608721337818_074" name="b" temporalId="s8_1_b"><num value="b">(b)</num><content>the person referred to in paragraph (a)(i) or (ii), as the case requires, has given the relevant consent.</content></paragraph></subsection><subsection id="ID_1608721337818_075" name="2" temporalId="s8_2"><num value="2">(2)</num><sourceNote>(Repealed <ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></subsection><subsection id="ID_1608721337834_078" name="3" temporalId="s8_3"><num value="3">(3)</num><content>Subsection (1) does not affect any other duty imposed by law or otherwise on a person who is responsible for administering an authorized vaccine.</content></subsection></section></part><part id="ID_1662523391934_001" name="P4" temporalId="P4" startPeriod="2022-09-09" status="operational" reason="inEffect"><num value="4">Part 4</num><heading>Requirements
            for Administration of Specified Vaccine other than under Government Vaccination
            Programme</heading><sourceNote>(<ref>Part 4</ref> added <ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote><section id="ID_1662523393103_002" name="s8A" temporalId="s8A" startPeriod="2022-09-09" status="operational" reason="inEffect"><num value="8A">8A.</num><heading>Collection and
            provision of information regarding administration of vaccine</heading><subsection id="ID_1662525063049_001" name="1" temporalId="s8A_1"><num value="1">(1)</num><leadIn>A registered medical practitioner who is responsible for administering a
                specified vaccine to a recipient other than under a Government vaccination programme
                must—</leadIn><paragraph id="ID_1662525063050_002" name="a" temporalId="s8A_1_a"><num value="a">(a)</num><leadIn>collect the following information—</leadIn><subparagraph id="ID_1662525063050_003" name="1" temporalId="s8A_1_a_1"><num value="1">(i)</num><content>the name of the recipient;</content></subparagraph><subparagraph id="ID_1662525063051_004" name="2" temporalId="s8A_1_a_2"><num value="2">(ii)</num><content>the date of birth of the recipient;</content></subparagraph><subparagraph id="ID_1662525063052_005" name="3" temporalId="s8A_1_a_3"><num value="3">(iii)</num><content>the sex of the recipient;</content></subparagraph><subparagraph id="ID_1662525063052_006" name="4" temporalId="s8A_1_a_4"><num value="4">(iv)</num><leadIn>the following information—</leadIn><subparagraph role="subSubparagraph" id="ID_1662525063053_007" name="A" temporalId="s8A_1_a_4_A"><num value="A">(A)</num><content>if the recipient is the holder of an identity card—the number of
                            the identity card; or</content></subparagraph><subparagraph role="subSubparagraph" id="ID_1662525063054_008" name="B" temporalId="s8A_1_a_4_B"><num value="B">(B)</num><content>otherwise—the type and number of a valid identification document of
                            the recipient;</content></subparagraph></subparagraph><subparagraph id="ID_1662525063054_009" name="5" temporalId="s8A_1_a_5"><num value="5">(v)</num><content>the name and batch number of the vaccine;</content></subparagraph><subparagraph id="ID_1662525063055_010" name="6" temporalId="s8A_1_a_6"><num value="6">(vi)</num><content>the date of the administration; and</content></subparagraph><subparagraph id="ID_1662525063056_011" name="7" temporalId="s8A_1_a_7"><num value="7">(vii)</num><content>the dose sequence of the vaccine; and</content></subparagraph></paragraph><paragraph id="ID_1662525063057_012" name="b" temporalId="s8A_1_b"><num value="b">(b)</num><leadIn>in accordance with subsection (2)—</leadIn><subparagraph id="ID_1662525063057_013" name="1" temporalId="s8A_1_b_1"><num value="1">(i)</num><content>report, or cause to be reported, to the Director the administration of
                        the vaccine; and</content></subparagraph><subparagraph id="ID_1662525063058_014" name="2" temporalId="s8A_1_b_2"><num value="2">(ii)</num><content>provide the Director with, or cause the Director to be provided with,
                        the information mentioned in paragraph (a).</content></subparagraph></paragraph></subsection><subsection id="ID_1662525063059_015" name="2" temporalId="s8A_2"><num value="2">(2)</num><leadIn>For subsection <ref>(1)(b)</ref>, the reporting and provision of information
                must be done—</leadIn><paragraph id="ID_1662525063060_016" name="a" temporalId="s8A_2_a"><num value="a">(a)</num><content>by using the eHealth System (Subsidies) or another electronic system
                    specified by the Director in place of the eHealth System (Subsidies);
                    and</content></paragraph><paragraph id="ID_1662525063061_017" name="b" temporalId="s8A_2_b"><num value="b">(b)</num><content>as soon as reasonably practicable (and, if a time is specified by the
                    Director, within that time) after the administration of the vaccine.</content></paragraph></subsection><subsection id="ID_1662525063062_018" name="3" temporalId="s8A_3"><num value="3">(3)</num><content>A matter to be specified by the Director under subsection (2) must be specified
                by means of a notice published on the website of the Department of Health.</content></subsection><subsection id="ID_1662525063062_019" name="4" temporalId="s8A_4"><num value="4">(4)</num><leadIn>In this section—</leadIn><def name="IdentityCard"><term>identity card</term> (<term xml:lang="zh-Hant-HK">身分證</term>) has the meaning given by <ref>section 1A(1)</ref> of the
                Registration of Persons Ordinance (<ref href="/hk/cap177">Cap. 177</ref>).</def></subsection></section><section id="ID_1662523393698_003" name="s8B" temporalId="s8B" startPeriod="2022-09-09" status="operational" reason="inEffect"><num value="8B">8B.</num><heading>Authorized
            officers</heading><subsection id="ID_1662525084166_001" name="1" temporalId="s8B_1"><num value="1">(1)</num><content>The Director may, in writing, appoint any public officer as an authorized
                officer for the purposes of this Part.</content></subsection><subsection id="ID_1662525084167_002" name="2" temporalId="s8B_2"><num value="2">(2)</num><content>An authorized officer must, if so required, produce written proof of his or her
                appointment before performing a function under <ref>section 8C</ref>.</content></subsection><subsection id="ID_1662525084169_003" name="3" temporalId="s8B_3"><num value="3">(3)</num><content>No personal liability is incurred by an authorized officer or a person acting
                under the officer’s direction in respect of any act done or omitted to be done by
                the officer or person in good faith in the performance or purported performance of a
                function under <ref>section 8C</ref>.</content></subsection><subsection id="ID_1662525084170_004" name="4" temporalId="s8B_4"><num value="4">(4)</num><content>Subsection (3) does not in any way affect any liability of the Government in
                respect of any act done or omitted to be done by an authorized officer or a person
                acting under the officer’s direction.</content></subsection></section><section id="ID_1662523393799_004" name="s8C" temporalId="s8C" startPeriod="2022-09-09" status="operational" reason="inEffect"><num value="8C">8C.</num><heading>Powers to
            conduct inquiry and require information etc.</heading><leadIn>If an authorized officer has reason to suspect that <ref>section 8A(1)</ref> is not
            being or has not been complied with, the officer may do any or all of the
            following—</leadIn><paragraph id="ID_1662525097941_001" name="a" temporalId="s8C_a"><num value="a">(a)</num><content>conduct any inquiry in order to obtain any information mentioned in
                    <ref>section 8A(1)(a)</ref>;</content></paragraph><paragraph id="ID_1662525097942_002" name="b" temporalId="s8C_b"><num value="b">(b)</num><content>require any person in possession of such information to provide the officer
                with such information;</content></paragraph><paragraph id="ID_1662525097943_003" name="c" temporalId="s8C_c"><num value="c">(c)</num><content>require any person to provide the officer with the assistance that the officer
                reasonably considers necessary to enable the officer to do anything mentioned in
                paragraph (a) or (b).</content></paragraph></section><section id="ID_1662523393912_005" name="s8D" temporalId="s8D" startPeriod="2022-09-09" status="operational" reason="inEffect"><num value="8D">8D.</num><heading>Obstruction of
            authorized officer etc. prohibited</heading><subsection id="ID_1662525110798_001" name="1" temporalId="s8D_1"><num value="1">(1)</num><content>A person must not delay, obstruct, hinder or molest an authorized officer who
                is performing a function under <ref>section 8C</ref>.</content></subsection><subsection id="ID_1662525110800_002" name="2" temporalId="s8D_2"><num value="2">(2)</num><content>A person must comply with a requirement made by an authorized officer under
                    <ref>section 8C(b)</ref> or (c).</content></subsection><subsection id="ID_1662525110802_003" name="3" temporalId="s8D_3"><num value="3">(3)</num><content>A person who contravenes subsection (1) or (2) commits an offence and is liable
                on conviction to a fine at level 3.</content></subsection><subsection id="ID_1662525110803_004" name="4" temporalId="s8D_4"><num value="4">(4)</num><content>It is a defence for a person charged under subsection (3) to establish that the
                person had reasonable excuse for the contravention.</content></subsection><subsection id="ID_1662525110804_005" name="5" temporalId="s8D_5"><num value="5">(5)</num><leadIn>A person is taken to have established a matter that needs to be established for
                a defence under subsection (4) if—</leadIn><paragraph id="ID_1662525110805_006" name="a" temporalId="s8D_5_a"><num value="a">(a)</num><content>there is sufficient evidence to raise an issue with respect to that matter;
                    and</content></paragraph><paragraph id="ID_1662525110806_007" name="b" temporalId="s8D_5_b"><num value="b">(b)</num><content>the contrary is not proved by the prosecution beyond reasonable
                    doubt.</content></paragraph></subsection><subsection id="ID_1662525110807_008" name="6" temporalId="s8D_6"><num value="6">(6)</num><content>A person who, in purported compliance with a requirement made under
                    <ref>section 8C(b)</ref>, knowingly or recklessly provides any information that
                is false or misleading in a material particular commits an offence and is liable on
                conviction to a fine at level 3.</content></subsection></section></part><part id="ID_1662523444805_001" name="P5" temporalId="P5" startPeriod="2022-09-09" status="operational" reason="inEffect"><num value="5">Part 5</num><heading>Miscellaneous</heading><sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote><section startPeriod="2020-12-24T00:00:00" status="operational" reason="inEffect" id="ID_1608721337834_079" name="s9" temporalId="s9"><num value="9">9.</num><heading>Advisory panel</heading><subsection id="ID_1608721337834_080" name="1" temporalId="s9_1"><num value="1">(1)</num><content>The Chief Executive may appoint a panel of persons who are considered by the Chief Executive to have relevant expertise for advising the Secretary for the purposes of <ref>section 3(3)</ref>, <ref>4(1)</ref> or <ref>6(1)</ref>.</content></subsection><subsection id="ID_1608721337850_081" name="2" temporalId="s9_2"><num value="2">(2)</num><content>A member of the advisory panel is not civilly liable for an act done or omitted to be done by the member in good faith in relation to the giving of advice for the purposes of <ref>section 3(3)</ref>, <ref>4(1)</ref> or <ref>6(1)</ref>.</content></subsection><subsection id="ID_1608721337865_082" name="3" temporalId="s9_3"><num value="3">(3)</num><content>Subsection (2) does not affect any liability of the Government for the act or omission referred to in that subsection.</content></subsection></section><section id="ID_1634021088565_001" name="s9A" temporalId="s9A" startPeriod="2022-09-09" status="operational" reason="inEffect"><num value="9A">9A.</num><heading>Immunity of members of certain committees and panel</heading><subsection id="ID_1634021623398_001" name="1" temporalId="s9A_1"><num value="1">(1)</num><leadIn>A member of any of the committees and panel specified in subsection (2) is not
                civilly liable for an act done or omitted to be done by the member in good faith in
                relation to the giving of advice to the Government in respect of—</leadIn><paragraph id="ID_1634021623400_002" name="a" temporalId="s9A_1_a"><num value="a">(a)</num><content>the use of
                    a
                    specified vaccine for a specified purpose; or</content></paragraph><paragraph id="ID_1634021623401_003" name="b" temporalId="s9A_1_b"><num value="b">(b)</num><content>any clinical event that occurs to a recipient in Hong Kong to whom
                    a
                    specified vaccine was administered for a specified purpose.
                    <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></content></paragraph></subsection><subsection id="ID_1634021623402_004" name="2" temporalId="s9A_2"><num value="2">(2)</num><leadIn>The committees and panel are—</leadIn><paragraph id="ID_1634021623403_005" name="a" temporalId="s9A_2_a"><num value="a">(a)</num><content>a committee established by the Department of Health
                        (<b><i>Department</i></b>) and known as the Expert Committee on Clinical
                    Events Assessment Following COVID-19 Immunisation;</content></paragraph><paragraph id="ID_1634021623404_006" name="b" temporalId="s9A_2_b"><num value="b">(b)</num><content>a committee established by the Department and known as the Scientific
                    Committee on Emerging and Zoonotic Diseases;</content></paragraph><paragraph id="ID_1634021623406_007" name="c" temporalId="s9A_2_c"><num value="c">(c)</num><content>a committee established by the Department and known as the Scientific
                    Committee on Vaccine Preventable Diseases; and</content></paragraph><paragraph id="ID_1634021623407_008" name="d" temporalId="s9A_2_d"><num value="d">(d)</num><content>a panel appointed by the Chief Executive for giving advice to the Chief
                    Executive in respect of the specified disease and known as the Chief Executive’s
                    Expert Advisory Panel.</content></paragraph></subsection><subsection id="ID_1634021623408_009" name="3" temporalId="s9A_3"><num value="3">(3)</num><content>Subsection (1) does not affect any liability of the Government for the act or
                omission referred to in that subsection.</content></subsection><sourceNote>(<ref href="hk/2021/ln234">L.N. 234 of 2021</ref>)</sourceNote></section><section startPeriod="2022-09-09" status="operational" reason="inEffect" id="ID_1608721337865_083" name="s10" temporalId="s10"><num value="10">10.</num><heading>Jurisdiction and immunity</heading><subsection id="ID_1608721337865_084" name="1" temporalId="s10_1"><num value="1">(1)</num><leadIn>Subsection (2) applies to a person who—</leadIn><paragraph id="ID_1608721337865_085" name="a" temporalId="s10_1_a"><num value="a">(a)</num><content>prescribes or dispenses
                    a
                    specified vaccine for administration to a recipient for
                    the
                    purpose of carrying out a Government vaccination programme;
                    or</content></paragraph><paragraph id="ID_1608721337865_086" name="b" temporalId="s10_1_b"><num value="b">(b)</num><content>is responsible for administering
                    a specified
                    vaccine to a recipient for the purpose of carrying out a Government vaccination programme.
                    <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of
                    2022</ref>)</sourceNote></content></paragraph></subsection><subsection id="ID_1608721337881_087" name="2" temporalId="s10_2"><num value="2">(2)</num><content>The person is not civilly liable for any loss or damage caused to the recipient
                by an act done or omitted to be done by the person in good faith in relation to the
                administration of the vaccine to the extent that the loss or damage results from any
                risk as to the safety of the administration of the vaccine attributable to the
                intrinsic property of the vaccine as manufactured.</content></subsection><subsection id="ID_1608721337881_088" name="3" temporalId="s10_3"><num value="3">(3)</num><content>Subsection (2) does not affect any liability of the Government or any person to
                whom that subsection does not apply for the loss or damage referred to in that
                subsection.</content></subsection><subsection id="ID_1662618780214_001" name="3A" temporalId="s10_3A"><num value="3A">(3A)</num><leadIn>For an act done or omitted to be done before the commencement<inline class="force_orig_font">*</inline> of the Prevention and Control of Disease (Use
                of Vaccines) (Amendment) <ref>Regulation 2022<sup>#</sup></ref>—</leadIn><paragraph id="ID_1662618780216_002" name="a" temporalId="s10_3A_a"><num value="a">(a)</num><content>subsections (1) and (2) as amended by the Regulation do not apply;
                    and</content></paragraph><paragraph id="ID_1662618780217_003" name="b" temporalId="s10_3A_b"><num value="b">(b)</num><content>subsections (1) and (2) as in force immediately before the
                        commencement<inline class="force_orig_font">*</inline> continue to apply.
                            <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of
                        2022</ref>)</sourceNote></content></paragraph></subsection><subsection id="ID_1608721337881_089" name="4" temporalId="s10_4"><num value="4">(4)</num><content>The courts of Hong Kong have exclusive jurisdiction over a claim of a recipient
                of an authorized vaccine administered for a specified purpose in relation to the
                vaccine. <sourceNote>(<ref href="hk/2020/er8">E.R. 8 of
                2020</ref>)</sourceNote></content></subsection></section><editorialNote type="footnote" id="ID_1664761466744_001">
        <content>Editorial Note:</content>
        <content><inline class="force_orig_font">*</inline> Commencement date: 9 September
            2022.</content>
        <content><sup>#</sup>
            <ref href="hk/2022/ln176">L.N. 176 of 2022</ref>.</content>
    </editorialNote><section startPeriod="2022-09-09" status="operational" reason="inEffect" id="ID_1608721337881_090" name="s11" temporalId="s11"><num value="11">11.</num><heading>Certain notices are not subsidiary legislation</heading><content>A notice published under <ref>section 3(6)</ref>, <ref>4(2)(b)</ref>,
                <ref>5(2)</ref>,
                <ref>6(3)(b)</ref> or <ref>8A(3)</ref> is not subsidiary
            legislation.</content><sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></section><section startPeriod="2022-09-09" status="operational" reason="inEffect" id="ID_1608721337881_091" name="s12" temporalId="s12"><num value="12">12.</num><heading>Expiry</heading><subsection id="ID_1608721337881_092" name="1" temporalId="s12_1"><num value="1">(1)</num><content>This Regulation expires at midnight on 23 December 2023.
                <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></content></subsection><subsection id="ID_1662602342934_001" name="2" temporalId="s12_2"><num value="2">(2)</num><leadIn>Despite subsection (1), the following provisions continue to have effect after
                the expiry of this Regulation as if those provisions had not expired—</leadIn><paragraph id="ID_1662602342935_002" name="a" temporalId="s12_2_a"><num value="a">(a)</num><content><ref>section 2</ref> (in so far as it relates to a provision set out in
                    paragraph (b) or (c));</content></paragraph><paragraph id="ID_1662602342936_003" name="b" temporalId="s12_2_b"><num value="b">(b)</num><content><ref>sections 8B(3)</ref> and (4), <ref>9(2)</ref> and (3), <ref>9A</ref>
                    and <ref>10(1)</ref>, (2), (3) and (3A) (in so far as they relate to an act done
                    or omitted to be done before the expiry of this Regulation); and</content></paragraph><paragraph id="ID_1662602342939_004" name="c" temporalId="s12_2_c"><num value="c">(c)</num><content><ref>section 10(4)</ref> (in so far as it relates to the administration of
                    an authorized vaccine before the expiry of this Regulation). <sourceNote>(<ref href="hk/2022/ln176">L.N. 176 of 2022</ref>)</sourceNote></content></paragraph></subsection><sourceNote>(<ref href="hk/2021/ln234">L.N. 234 of 2021</ref>)</sourceNote></section></part></main></subLeg>